Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis

Clinica Chimica Acta

Volumn 294, Issue 1-2, 2000, Pages 169-177

  Nikolić, J Anna ^a   Todorović, Vera ^b   Božić, Milena ^c   Tošić, Ljubinka ^b   Bulajić, Mirko ^d   Alempijević, Tamara ^d   Nedić, Olgica ^a   Masnikosa, Romana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d Institute of Digestive Diseases   (Yugoslavia)

Author keywords

Human serum; IGF I, IGF II; Liver cirrhosis; Radioimmunoassay

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD SAMPLING; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VIRUS HEPATITIS;

ADULT; AGE FACTORS; AGED; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; MALE; MIDDLE AGED; REFERENCE VALUES; SEX FACTORS;

EID: 0034015142     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00254-5     Document Type: Article

References (20)

1. Wu J.-C., Daughaday W.H., Lee S.-D., et al. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med. 112:1988;589-594.
2. Blomsma M.C., de Knegt R.J., Dullaart R.P.F., Jansen P.L.M. Insulin-like growth factor-I in liver cirrhosis. J Hepatol. 27:1997;1133-1138.
3. Caregaro L., Alberino F., Amodio P., et al. Nutritional and prognostic significance of insulin-like growth factor-1 in patients with liver cirrhosis. Nutrition. 13:1997;185-190.
4. Kratzsch J., Blum W.F., Schenker E., Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF-binding proteins -1,-2,-3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol. 103:1995;285-291.
5. Assy N., Hochberg Z., Amit T., Shen-Orr Z., Enat R., Baruch Y. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol. 27:1997;796-802.
6. Assy N., Hochberg Z., Enat R., Baruch Y. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci. 43:1998;1317-1321.
7. Juul A., Bang P., Hertel N., et al. Serum insulin-like growth factor-I in healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab. 78:1994;744-752.
8. Nyström F.H., Öhman P.K., Ekman B.Å., Österland M.K., Karlberg B.E., Arnqvist H.J. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Eur J Endocrinol. 136:1997;165-172.
9. O'Connor K.G., Tobin J.D., Harman M., et al. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol Med Sci. 53A:1998;M176-182.
10. Rodenburg R.J.T., Krijger J.-J.T., Holthuizen E., Sussenbach J.S. The liver-specific promoter of the human insulin-like growth factor-II gene contains two negative regulatory elements. FEBS Lett. 394:1996;25-30.
11. Nikolić J.A., Masnikosa R., Nedić O. Peripheral serum concentrations of insulin-like growth factor-I (IGF-I) and IGF-II in healthy men and women and patients with different diseases. Jugoslov Med Biochem. 17:1998;302-303.
12. Nikolić J.A., Nedić O., Masnikosa R. Determination of insulin-like growth factor-II in human serum. J Serb Chem Soc. 63:1998;805-815.
13. Nikolić J.A., Ratković M., Nedić O. Determination of insulin-like growth factor-I by radioimmunoassay. J Serb Chem Soc. 61:1996;177-183.
14. Bang P., Baxter R.C., Blum W.F., et al. Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd international symposium on insulin-like growth factors. Endocrinology. 136:1995;816-817.
15. Baxter R.C., de Mellow J.S.M. Measurement of insulin-like growth factor-II by radioreceptor assay using ovine placental membranes. Clin Endocrinol. 24:1986;267-278.
16. Benbassat C.A., Maki K.C., Unterman T.G. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab. 82:1997;1494-1501.
17. Ceda G.N.P., Dall'Aglio E., Magnacavallo A., et al. The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab. 83:1998;499-502.
18. Sheppard M.S., Minuk G.Y., Bhaumick B., Bala R.M. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II. Clin Invest Med. 10:1987;49-53.
19. Scharf J.-G., Schmitz F., Frystyk J., et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol. 25:1996;689-699.
20. Shmeuli E., Miell J.P., Stewart M., Alberti G.M.M., Record C.O. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. J Hepatol. 24:1996;127-133.